Francois Lebel is Chief Medical Officer at SPECTRUM PHARMACEUTICALS INC (SPPI). They have made 3 open-market trades across 2 companies since 2015, most recently 2022-06-23.
CIK 0001038704
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SPPI | SELL · 10b5-1 | 2022-06-22 | 2022-06-23 | $0.83 | $11K | -8.2% | -7.0% | -27.9% |
| SPPI | SELL · 10b5-1 | 2022-04-04 | 2022-04-05 | $1.38 | $4K | -31.1% | -34.1% | -38.6% |
| SPPI | SELL · 10b5-1 | 2022-03-15 | 2022-03-16 | $0.71 | $36K | +63.6% | +16.4% | +0.6% |
| SPPI | SELL · 10b5-1 | 2022-02-23 | 2022-02-24 | $0.67 | $19K | +2.6% | +75.0% | -1.4% |
| SPPI | SELL · 10b5-1 | 2021-11-08 | 2021-11-10 | $2.19 | $29K | -18.5% | -32.7% | -70.0% |
| SPPI | SELL · 10b5-1 | 2021-06-22 | 2021-06-23 | $4.05 | $44K | -10.6% | -17.9% | -41.1% |
| SPPI | SELL · 10b5-1 | 2021-04-05 | 2021-04-06 | $3.28 | $7K | -5.4% | -5.7% | +12.0% |
| SPPI | SELL | 2021-03-15 | 2021-03-17 | $3.66 | $303K | -12.4% | -15.3% | +20.6% |
| SPPI | SELL · 10b5-1 | 2020-11-06 | 2020-11-09 | $3.52 | $42K | +10.4% | +22.1% | +2.9% |
| SPPI | SELL · 10b5-1 | 2020-06-22 | 2020-06-23 | $3.24 | $31K | +10.0% | +1.9% | +48.3% |
| SPPI | SELL · 10b5-1 | 2020-04-02 | 2020-04-06 | $2.17 | $5K | +14.6% | +20.5% | +47.7% |
| SPPI | SELL | 2019-11-06 | 2019-11-08 | $8.16 | $114K | +2.1% | +20.9% | -66.5% |
| ZIOP | SELL | 2015-06-09 | 2015-06-11 | $10.12 | $506K | -29.4% | -0.6% | -0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.